FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380763289> ?p ?o ?g. }

• W4380763289 abstract "Vascular calcification is prevalent in patients with diabetes mellitus and well documented in animal models of diabetes. We have previously reported that vascular calcification in diabetes is associated with elevated vascular protein O -linked GlcNAc modification ( O -GlcNAcylation). The present studies sought to determine a causative link of O -GlcNAcylation with diabetic vascular calcification and the underlying molecular mechanisms. Using coronary arteries from diabetic subjects, we identified increased O -GlcNAcylation in the highly calcified lesions compared to those in the surrounding uncalcified areas. By generating a new mouse model with inducible SMC-specific deletion of the O -GlcNAc transferase (OGT), we demonstrated that smooth muscle cell (SMC)-specific OGT deletion significantly inhibited protein O -GlcNAcylation and calcification, and decreased aortic stiffness in the low-dose streptozotocin-induced diabetic mice. Consistent with the observations in human tissues, inhibition of vascular calcification by OGT ablation was associated with down-regulation of Runx2, the essential osteogenic regulator for vascular calcification. OGT deficiency in VSMC further attenuated Runx2-induced VSMC calcification. Immunoprecipitation analysis uncovered a direct O-GlcNAc modification on Runx2, which was abolished in the OGT-deficient VSMC. With a serial of Runx2 truncation mutants and point mutations on putative O -GlcNAcylation sites, we localized the essential Runx2 osteogenic functional domain between amino acids 391 and 432, and identified Runx2 T412 was responsible for Runx2 O -GlcNAcylation and Runx2-induced VSMC calcification. Inhibition of Runx2 O -GlcNAcylation by T412A mutation decreased Runx2 transcription activity and inhibited Runx2 binding with its key co-factors. Taken together, our studies have provided the first genetic proof demonstrating the causative effects of O -GlcNAcylation on vascular calcification in diabetes, and identified a novel mechanism underlying the essential role of O -GlcNAcylation of Runx2 in Runx2 osteogenic activity and Runx2-induced VSMC calcification. These results may shed lights on novel targets that are amenable to drug discovery for diabetic vascular calcification." @default.
• W4380763289 created "2023-06-16" @default.
• W4380763289 creator A5006353852 @default.
• W4380763289 creator A5032742597 @default.
• W4380763289 creator A5038178209 @default.
• W4380763289 creator A5052953228 @default.
• W4380763289 creator A5060948677 @default.
• W4380763289 creator A5065673727 @default.
• W4380763289 creator A5065704094 @default.
• W4380763289 date "2022-11-08" @default.
• W4380763289 modified "2023-10-16" @default.
• W4380763289 title "Abstract 15322: O-glcnac Modification on Runx2 Promotes Vascular Calcification" @default.
• W4380763289 doi "https://doi.org/10.1161/circ.146.suppl_1.15322" @default.
• W4380763289 hasPublicationYear "2022" @default.
• W4380763289 type Work @default.
• W4380763289 citedByCount "0" @default.
• W4380763289 crossrefType "journal-article" @default.
• W4380763289 hasAuthorship W4380763289A5006353852 @default.
• W4380763289 hasAuthorship W4380763289A5032742597 @default.
• W4380763289 hasAuthorship W4380763289A5038178209 @default.
• W4380763289 hasAuthorship W4380763289A5052953228 @default.
• W4380763289 hasAuthorship W4380763289A5060948677 @default.
• W4380763289 hasAuthorship W4380763289A5065673727 @default.
• W4380763289 hasAuthorship W4380763289A5065704094 @default.
• W4380763289 hasConcept C104317684 @default.
• W4380763289 hasConcept C126322002 @default.
• W4380763289 hasConcept C134018914 @default.
• W4380763289 hasConcept C2776363554 @default.
• W4380763289 hasConcept C2779395532 @default.
• W4380763289 hasConcept C2780309369 @default.
• W4380763289 hasConcept C2992686903 @default.
• W4380763289 hasConcept C55493867 @default.
• W4380763289 hasConcept C71924100 @default.
• W4380763289 hasConcept C86339819 @default.
• W4380763289 hasConcept C86803240 @default.
• W4380763289 hasConcept C95444343 @default.
• W4380763289 hasConceptScore W4380763289C104317684 @default.
• W4380763289 hasConceptScore W4380763289C126322002 @default.
• W4380763289 hasConceptScore W4380763289C134018914 @default.
• W4380763289 hasConceptScore W4380763289C2776363554 @default.
• W4380763289 hasConceptScore W4380763289C2779395532 @default.
• W4380763289 hasConceptScore W4380763289C2780309369 @default.
• W4380763289 hasConceptScore W4380763289C2992686903 @default.
• W4380763289 hasConceptScore W4380763289C55493867 @default.
• W4380763289 hasConceptScore W4380763289C71924100 @default.
• W4380763289 hasConceptScore W4380763289C86339819 @default.
• W4380763289 hasConceptScore W4380763289C86803240 @default.
• W4380763289 hasConceptScore W4380763289C95444343 @default.
• W4380763289 hasIssue "Suppl_1" @default.
• W4380763289 hasLocation W43807632891 @default.
• W4380763289 hasOpenAccess W4380763289 @default.
• W4380763289 hasPrimaryLocation W43807632891 @default.
• W4380763289 hasRelatedWork W1965794701 @default.
• W4380763289 hasRelatedWork W1995523086 @default.
• W4380763289 hasRelatedWork W1997650562 @default.
• W4380763289 hasRelatedWork W2122859970 @default.
• W4380763289 hasRelatedWork W2143238233 @default.
• W4380763289 hasRelatedWork W2322404450 @default.
• W4380763289 hasRelatedWork W4245472597 @default.
• W4380763289 hasRelatedWork W4250247120 @default.
• W4380763289 hasRelatedWork W4252056010 @default.
• W4380763289 hasRelatedWork W2044583677 @default.
• W4380763289 hasVolume "146" @default.
• W4380763289 isParatext "false" @default.
• W4380763289 isRetracted "false" @default.
• W4380763289 workType "article" @default.